RA Capital Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

RA Capital Management’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-3,333	Closed	-$1.33M	–	64
2015 Q2	$1.33M	Hold	3,333	–	–	0.13%	43
2015 Q1	$1.64M	Hold	3,333	–	–	0.16%	43
2014 Q4	$1.19M	Hold	3,333	–	–	0.13%	40
2014 Q3	$643K	Buy	+3,333	New	+$733K	0.08%	46
2013 Q4	–	Sell	-204,477	Closed	-$36.4M	–	39
2013 Q3	$34.6M	Hold	204,477	–	–	3.61%	10
2013 Q2	$36.3M	Buy	+204,477	New	+$29M	4.81%	7

Other funds holding LUMO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

TAM

Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

RA Capital Management's LUMO Position: Q3 2015 in Review

RA Capital Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2015, closing a stake of 3,333 shares — an estimated $1.33M sold.

RA Capital Management first reported a position in LUMO in Q2 2013 and held it in 6 quarters. The position peaked at $36.3M in Q2 2013. 152 funds tracked by Wall St. Rank hold LUMO as of Q3 2015.

RA Capital Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
RA Capital Management sold 3,333 Lumos Pharma, Inc. Common Stock shares in Q3 2015, an estimated $1.33M.
RA Capital Management first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 6 quarters.
RA Capital Management's Lumos Pharma, Inc. Common Stock position peaked at $36.3M in Q2 2013.
152 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2015.

Based on RA Capital Management's 13F filing for Q3 2015, filed 13 Nov 2015.